ZOM News and Press, Zomedica Pharmaceuticals Corp. From 06/13/22

ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, has initiated a study to evaluate shock wave therapy as a treatment for Exercised Ind...

ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce today that Larry Heaton, Zomedica's Chief Executiv...

3 Top Penny Stocks to Add to Your Watchlist Right Now With added bullish sentiment in the stock market right now, there are a lot of penny stocks that could be worth watching right now. But, to understand which penny stocks are worth buying, it’s important to do your research...

The veterinary health company Zomedica (NYSE:ZOM) announced Thursday the purchase of a $1.0 million convertible note of Ohio-based animal care company Structured Monitoring Products, Inc. giving it an option to act as a sales agent for SMP's platform. Per the terms of the agreement, Zomedica ...

ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it has purchased a $1.0 million convertible note from Structured ...

NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a new C-Level interview featuring Larry Heaton, CEO of Zomedica Corp. Mark Roberts, Senior E...

ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce the interview with Juan Costello, Senior Analyst w...

Check These 3 Penny Stocks Out For Your Watchlist As we end another week of trading penny stocks and blue chips, there is a lot for investors to keep in mind. Despite mostly positive sentiment as the week ended, penny stocks and blue chips have been in a blood bath in the past few m...

Zomedica press release (NYSE:ZOM): Q1 net loss of $3.9M. Revenue of $3.8M. Total revenues of $3.8 million were up 38% over the combined revenues of Zomedica and PulseVet as a standalone company of $2.7 million. For further details see: Zomedica reports Q1 results

ANN ARBOR, MI / ACCESSWIRE / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three months ended March ...